Photocat A/S
Highlights during the second half year of 2020
- Revenue in the second half year of 2020 was 5,463.9 tDKK which compared to second
half 2019 was an increase of 92,9% - For the full year Revenue grew 80,6 % in the year 2020 compared to the year 2019.
- Photocat was granted 2 patent families in the areas dry concrete as well as bitumen.
These are important because they protect Photocat and might offer the possibility of
creating a new business to offer license to companies that lack freedom to operate
without our rights. - Delivered NOxOFF concrete granulates to Colas for projects in the municipality of Frederiksberg
and the technology was appreciated with news releases from Colas. Further we delivered
NOxOFF granulates to NCC Road to be used on the new harbour tier in Skagen. Both projects
were delivered without complications and this asphalt product makes good possibilities to
extent Photocat’s offerings to include asphalt roads - First scientific article with results from Photocat real-life projects was published in a
peer reviewed magazine. The results showed clear benefits of Photocat solutions. - Covid-19 did have impact on all Photocat export initiatives as borders and travel
recommendations were making planning impossible. This had a negative effect on the results.
Highlights after the second half year of 2020
- Granted Covid-19 finance facilities from Vaekstfonden in Denmark
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma18.7.2025 18:30:00 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
SpringWorks Therapeutics, Inc.18.7.2025 17:30:40 CEST | Press release
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
Photocat A/S18.7.2025 17:00:00 CEST | Press release
PHOTOCAT has today applied for a transfer of its trading venue from Nasdaq First North Growth Market to Spotlight Stock Market.
Golden Ocean Group Limited18.7.2025 16:30:00 CEST | Press release
GOGL – Notice of Special General Meeting
Kapitalforeningen SDG Invest18.7.2025 16:06:31 CEST | Pressemeddelelse
Kapitalforeningen SDG Invest - Opdateret prospekt
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom